Cargando…
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita
Mutations in the TINF2 gene, encoding the shelterin protein TIN2, cause telomere shortening and the inherited bone marrow (BM) failure syndrome dyskeratosis congenita (DC). A lack of suitable model systems limits the mechanistic understanding of telomere shortening in the stem cells and thus hinders...
Autores principales: | Choo, Seunga, Lorbeer, Franziska K., Regalado, Samuel G., Short, Sarah B., Wu, Shannon, Rieser, Gabrielle, Bertuch, Alison A., Hockemeyer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373014/ https://www.ncbi.nlm.nih.gov/pubmed/35421215 http://dx.doi.org/10.1182/blood.2021013750 |
Ejemplares similares
-
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes
por: Walne, Amanda J., et al.
Publicado: (2008) -
Novel Mutation of the TINF2 Gene in a Patient with Dyskeratosis Congenita
por: Panichareon, Benjaporn, et al.
Publicado: (2015) -
Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita
por: Roake, Caitlin M., et al.
Publicado: (2021) -
Novel TINF2 gene mutation in dyskeratosis congenita with extremely short telomeres: A case report
por: Picos-Cárdenas, Verónica Judith, et al.
Publicado: (2022) -
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
por: Schmutz, Isabelle, et al.
Publicado: (2020)